The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Role of interleukin‐1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage
Abstract
Objective: To determine whether interleukin‐1 (IL‐1) or tumor necrosis factor α (TNFα), or both, plays a role in the excessive degradation that is observed in cultured osteoarthritic (OA) articular cartilage. Methods: Antagonists of IL‐1 and TNFα, namely, IL‐1 receptor antagonist and the PEGylated soluble TNFα receptor I, respectively, were added at different concentrations to explant cultures of nonarthritic (5 obtained at autopsy) and OA (15 obtained at arthroplasty) articular cartilage. The cleavage of type II collagen (CII) by collagenase was measured by an immunoassay in cartilage and culture media. Proteoglycan (mainly aggrecan) content and degradation were measured by a colorimetric assay for glycosaminoglycan (GAG) content in cartilage and culture media. Reverse transcriptase–polymerase chain reaction was used to analyze gene expression of matrix metalloproteases (MMPs) 1, 3, and 13, CII, aggrecan, IL‐1, and TNFα. Results: Antagonists of IL‐1 and TNFα inhibited the increase in CII cleavage by collagenase as well as the increase in GAG release observed in OA cartilage compared with normal cartilage. Inhibition was significant in tissue from some patients but not from others, although significant inhibition was observed when all the results were analyzed together. An increase in the GAG content in cartilage was seen in 4 of 15 cases. However, this increase was not significant when all the data were combined. Preliminary results indicated no effect of these antagonists on nonarthritic cartilage from 3 different donors. Independent analyses of gene expression in cultured cartilage from 9 other OA patients revealed that IL‐1 or TNFα blockade, either alone and/or in combination, frequently down‐regulated MMP‐1, MMP‐3, and MMP‐13 expression. Expression of IL‐1 and TNFα was inhibited by either antagonist or by the combination in essentially half the cases. The combined blockade up‐regulated aggrecan and CII gene expression in approximately half the cases. Conclusion: These results suggest that the autocrine/paracrine activities of TNFα and IL‐1 in articular cartilage may play important roles in cartilage matrix degradation in OA patients but not in all patients. Inhibition of either or both of these cytokines may offer a useful therapeutic approach to the management of OA by reducing gene expression of MMPs involved in cartilage matrix degradation and favoring its repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
FARNDALE, R., BUTTLE, D., & BARRETT, A. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90306-5 · Cited by 3,312
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C., Mitchell, P., Hambor, J., Diekmann, O., Tschesche, H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119316 · Cited by 968
Self-citationMolecular cloning and expression of a receptor for human tumor necrosis factor
Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90816-w · Cited by 964
Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F., & Hambor, J. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118475 · Cited by 940
Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
Loetscher, H., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., Tabuchi, H., & Lesslauer, W. (1990) · Cell · doi:10.1016/0092-8674(90)90815-v · Cited by 905
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
The role of the chondrocyte in osteoarthritis
Goldring, M. B. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1916::aid-anr2>3.0.co;2-i · Cited by 713
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, J. A., & Woody, J. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90632-7 · Cited by 640
Hollander, A. P., Heathfield, T. F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C., & Poole, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117156 · Cited by 611
Self-citationCarter, D. B., Deibel, M. R., Dunn, C. J., Tomich, C.-S. C., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., et al. (1990) · Nature · doi:10.1038/344633a0 · Cited by 601
Hollander, A. P., Pidoux, I., Reiner, A., Rorabeck, C., Bourne, R., & Poole, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118357 · Cited by 485
Self-citationLark, M. W., Bayne, E. K., Flanagan, J., Harper, C. F., Hoerrner, L. A., Hutchinson, N. I., Singer, I. I., Donatelli, S. A., Weidner, J. R., Williams, H. R., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119526 · Cited by 470
KEMPSON, G., MUIR, H., POLLARD, C., & TUKE, M. (1973) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(73)90093-7 · Cited by 453
Goldring, M. B., Birkhead, J., Sandell, L. J., Kimura, T., & Krane, S. M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113823 · Cited by 397
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Arthritis and Allied Conditions: A Textbook of Rheumatology
Smyth, C. J. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03360180182053 · Cited by 322
Osteoarthritic Lesions. Involvement of three different collagenases
Shlopov, B. V., Lie, W., Mainardi, C. L., Cole, A. A., Chubinskaya, S., & Hasty, K. A. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401120 · Cited by 305
Dodge, G. R., & Poole, A. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113929 · Cited by 294
Self-citationCartilage in health and disease
Poole, A. (1997) · Medical Entomology and Zoology · Cited by 264
Self-citationRizkalla, G., Reiner, A., Bogoch, E., & Poole, A. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116113 · Cited by 250
Self-citationCampion, G. V., Lebsack, M. E., Lookabaugh, J., & Gordon, G. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390704 · Cited by 247
Dahlberg, L., Billinghurst, R. C., Manner, P., Nelson, F., Webb, G., Ionescu, M., Reiner, A., Tanzer, M., Zukor, D., Chen, J., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<673::aid-anr25>3.0.co;2-8 · Cited by 238
Self-citationIn Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee Joints
Fernandes, J., Tardif, G., Martel-Pelletier, J., Lascau-Coman, V., Dupuis, M., Moldovan, F., Sheppard, M., Krishnan, B. R., & Pelletier, J.-P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65368-0 · Cited by 219
Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes
Borden, P., Solymar, D., Sucharczuk, A., Lindman, B., Cannon, P., & Heller, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23577 · Cited by 178
TNF induces internalization of the p60 receptor and shedding of the p80 receptor.
Higuchi, M., & Aggarwal, B. B. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3550 · Cited by 171
Billinghurst, R. C., Wu, W. K. K., Ionescu, M., Reiner, A., Dahlberg, L., Chen, J. W., Wart, H. V., & Poole, A. R. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<664::aid-anr24>3.0.co;2-d · Cited by 161
Self-citationPoole, A. R., Rosenberg, L. C., Reiner, A., Ionescu, M., Bogoch, E. R., & Roughley, P. J. (1996) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100140502 · Cited by 132
Self-citationAttur, M. G., Dave, M. N., Cipolletta, C., Kang, P., Goldring, M. B., Patel, I. R., Abramson, S. B., & Amin, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002721200 · Cited by 126
Slack, J. L., McMahan, C. J., Waugh, S. M., Schooley, K., Spriggs, M. K., Sims, J. E., & Dower, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53806-0 · Cited by 108
Tchetina, E. V., Mwale, F., & Poole, A. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.844 · Cited by 101
Self-citationCi, W., Atkins, R., Dieppe, P. A., & Cj, E. (1994) · PubMed · Cited by 76
Amin, A. R. (1999) · Osteoarthritis and Cartilage · doi:10.1053/joca.1998.0221 · Cited by 73
Cellular Biology of Cartilage Degradation
Poole, A. R., Alini, M., & Hollander, A. P. (1995) · Elsevier eBooks · doi:10.1016/b978-012340440-4/50041-6 · Cited by 50
Self-citationPRIMER ON THE RHEUMATIC DISEASES
Committee of the American Rheumatism Association (1959) · JAMA · doi:10.1001/jama.1959.73010280009016 · Cited by 24
Cited by
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778
Proteases involved in cartilage matrix degradation in osteoarthritis
Troeberg, L., & Nagase, H. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.06.020 · Cited by 579
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Stannus, O., Jones, G., Cicuttini, F., Parameswaran, V., Quinn, S., Burgess, J., & Ding, C. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.08.016 · Cited by 510
535 East 70th Street, C. R. B., Goldring, M., Otero, M., Plumb, D., Dragomir, C., Favero, M., EI Hachem, K., Hashimoto, K., Roach, H., Olivotto, E., et al. (2011) · European Cells and Materials · doi:10.22203/ecm.v021a16 · Cited by 489
Metadata
- Authors
- Kobayashi, M., Squires, G. R., Mousa, A., Tanzer, M., Zukor, D. J., Antoniou, J., Feige, U., & Poole, A. R.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-01
- Volume
- 52
- Issue
- 1
- Pages
- 128-135
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2053342448
- Cited by
- 497
- References
- 40
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.